⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29496072 | 0.69 | — | — | |
| SCHEMBL28586867 | 0.67 | — | — | |
| SCHEMBL28007944 | 0.67 | — | — | |
| SCHEMBL29536209 | 0.65 | — | — | |
| SCHEMBL3092759 | 0.65 | — | — | |
| SCHEMBL30642048 | 0.65 | — | — | |
| SCHEMBL10924096 | 0.65 | — | — | |
| SCHEMBL4743540 | 0.63 | — | — | |
| SCHEMBL29824274 | 0.62 | — | — | |
| SCHEMBL29027353 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113398127-A | Use of methyl oxfordine or citrate thereof for preventing or treating HIV related neurocognitive dysfunction | 南方医科大学 | 2021-09-17 | — | — | CN | claimed |
| EP-4298908-A2 | TRICYCLIC CARBOXAMIDES FOR THE CONTROL OF ARTHROPODS | Bayer Animal Health GmbH (DE) | 2024-01-03 | — | — | EP | disclosed |
| US-11825838-B2 | Tricyclic carboxamides for controlling arthropods | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2023-11-28 | — | — | US | disclosed |
| EP-3601279-B1 | TRICYCLIC CARBOXAMIDES AS CONTROL AGENT FOR ARTHROPODS | BAYER ANIMAL HEALTH GMBH (DE) | 2023-10-18 | — | — | EP | disclosed |
| CN-111233873-B | Application of methyl taurocten in preparation of drugs for inhibiting proliferation and inducing differentiation of leukemia cells and leukemia stem cells | 潍坊医学院 | 2023-01-24 | — | — | CN | disclosed |
| CN-113398127-A | Use of methyl oxfordine or citrate thereof for preventing or treating HIV related neurocognitive dysfunction | 南方医科大学 | 2021-09-17 | — | — | CN | disclosed |
| CN-113398127-A | Use of methyl oxfordine or citrate thereof for preventing or treating HIV related neurocognitive dysfunction | 南方医科大学 | 2021-09-17 | — | — | CN | disclosed |
| US-20210106005-A1 | TRICYCLIC CARBOXAMIDES FOR CONTROLLING ARTHROPODS | ELANCO ANIMAL HEALTH GMBH (DE) | 2021-04-15 | — | — | US | disclosed |
| CN-108137509-B | Pyrrole, oxadiazole, triazole or tetrazole derivatives suitable for controlling arthropods | 拜耳作物科学股份公司 | 2021-03-19 | — | — | CN | disclosed |
| EP-3169674-B1 | ARYL-TRIAZOLYL-PYRIDINES AS PESTICIDES | BAYER ANIMAL HEALTH GMBH (DE) | 2021-01-20 | — | — | EP | disclosed |
| WO-2010133312-A1 | HALOGEN-SUBSTITUTED COMPOUNDS AS PESTICIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2010-11-25 | — | — | WO | disclosed |
| EP-2253617-A1 | Halogenated compounds as pesticides | Bayer CropScience AG (DE) | 2010-11-24 | — | — | EP | disclosed |
| US-20100234312-A1 | AVERMECTIN DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2010-09-16 | — | — | US | disclosed |
| EP-2054427-B1 | AVERMECTIN DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2010-07-14 | — | — | EP | disclosed |
| EP-2184273-A1 | Halogen substituted compounds as pesticides | Bayer CropScience AG (DE) | 2010-05-12 | — | — | EP | disclosed |
| WO-2009141096-A1 | SUBSTITUTED SPIRO-ISOXAZOLINES | BAYER CROPSCIENCE AG (DE) | 2009-11-26 | — | — | WO | disclosed |
| US-20090238763-A1 | HIGH PENETRATION COMPOSITIONS AND USES THEREOF | TECHFIELDS PHARMA CO., LTD. (CN) | 2009-09-24 | — | — | US | disclosed |
| EP-2054427-A2 | AVERMECTIN DERIVATIVES | Bayer CropScience AG (DE) | 2009-05-06 | — | — | EP | disclosed |
| WO-2008019784-A2 | AVERMECTIN DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2008-02-21 | — | — | WO | disclosed |
| CN-1764456-A | Treatment of related diseases using full alpha-7 nACh receptor agonists | PHARMACIA & UPJOHN CO LLC (US) | 2006-04-26 | — | — | CN | disclosed |